Unlocking Growth: TCBP’s Latest Acquisition Strategy and Target Updates Revealed!
Unlocking Growth: TCBP’s Latest Acquisition Strategy and Target Updates Revealed! Introduction EDINBURGH, Scotland , Dec. 31, 2024 /PRNewswire/ — TC BioPharm (Holdings) PLC (“TC BioPharm” or the “Company”) (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T-cell therapies for cancer and other indications, today announced it has advanced